|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1999-5-27
|
|
pubmed:abstractText |
Payment for care provided as part of clinical research has become less predictable as a result of managed care. Because little is known at present about how entry into cancer trials affects the cost of care for cancer patients, we conducted a matched case-control comparison of the incremental medical costs attributable to participation in cancer treatment trials.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
19
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
847-53
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10340904-Cancer Care Facilities,
pubmed-meshheading:10340904-Case-Control Studies,
pubmed-meshheading:10340904-Clinical Trials, Phase II as Topic,
pubmed-meshheading:10340904-Clinical Trials, Phase III as Topic,
pubmed-meshheading:10340904-Clinical Trials as Topic,
pubmed-meshheading:10340904-Female,
pubmed-meshheading:10340904-Hospital Costs,
pubmed-meshheading:10340904-Hospitals, Group Practice,
pubmed-meshheading:10340904-Humans,
pubmed-meshheading:10340904-Male,
pubmed-meshheading:10340904-Matched-Pair Analysis,
pubmed-meshheading:10340904-Minnesota,
pubmed-meshheading:10340904-Neoplasms,
pubmed-meshheading:10340904-Patient Selection,
pubmed-meshheading:10340904-United States
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Incremental costs of enrolling cancer patients in clinical trials: a population-based study.
|
|
pubmed:affiliation |
Congressional Budget Office, Washington, DC, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
